May 28, 2019 Interview with our CEO Dr. Frank Mathias on the expansion to USA
Rentschler Biopharma has acquired a new site in the USA, near Boston, thus expanding its global presence.
With our new production site, we are able to answer our U.S. clients' strong requests to bring our innovation and Technology to their doorstep, underscoring our deep commitment to meeting their unique market needs.
Our new site has a 93,000 sp. ft. facility, is state-of-the-art and approved by the FDA and EMA. We thus take over a fully functional site with space for extensions.
If you would like to learn more about the strategic background and future plans of our new US site, please read the full German interview in the | transkript Magazin.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication